Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rolf Rau

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
The Journal of Rheumatology|April 3, 2003
Intravenous human recombinant tumor necrosis factor receptor p55-Fc IgG1 fusion protein Ro 45-2081 (lenercept): a double blind, placebo controlled dose-finding study in rheumatoid arthritisRolf Rau, Oliver Sander, Piet van Riel, et al.
RMD Open|July 3, 2021
Hydroxychloroquine in patients with inflammatory and erosive osteoarthritis of the hands: results of the OA-TREAT study-a randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trialClaudia Kedor, Jacqueline Detert, Rolf Rau, et al.
Arthritis and Rheumatism|April 16, 2002
How to report radiographic data in randomized clinical trials in rheumatoid arthritis: guidelines from a roundtable discussionDésirée van der Heijde, Lee Simon, Josef Smolen, et al.
Arthritis Research & Therapy|July 4, 2007
Expert agreement confirms that negative changes in hand and foot radiographs are a surrogate for repair in patients with rheumatoid arthritisDésirée van der Heijde, Robert Landewé, Annelies Boonen, et al.
Arthritis and Rheumatism|April 29, 2006
Association of the IL4R single-nucleotide polymorphism I50V with rapidly erosive rheumatoid arthritisIryna Prots, Alla Skapenko, Jörg Wendler, et al.
Arthritis and Rheumatism|October 29, 2005
Infections in patients with rheumatoid arthritis treated with biologic agentsJoachim Listing, Anja Strangfeld, Sonja Kary, et al.
The Journal of Rheumatology|November 5, 2002
A single dose, placebo controlled study of the fully human anti-tumor necrosis factor-alpha antibody adalimumab (D2E7) in patients with rheumatoid arthritisAlfons den Broeder, Leo van de Putte, Rolf Rau, et al.
The Journal of Rheumatology|May 8, 2003
Repair of erosions in rheumatoid arthritis does occur. Results from 2 studies by the OMERACT Subcommittee on Healing of ErosionsJohn T Sharp, Désirée Van Der Heijde, Maarten Boers, et al.
Annals of the Rheumatic Diseases|June 29, 2012
Induction therapy with adalimumab plus methotrexate for 24 weeks followed by methotrexate monotherapy up to week 48 versus methotrexate therapy alone for DMARD-naive patients with early rheumatoid arthritis: HIT HARD, an investigator-initiated studyJacqueline Detert, Hans Bastian, Joachim Listing, et al.
Annals of the Rheumatic Diseases|April 7, 2007
QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countriesTuulikki Sokka, Hannu Kautiainen, Sergio Toloza, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
The Journal of Rheumatology|April 3, 2003
Intravenous human recombinant tumor necrosis factor receptor p55-Fc IgG1 fusion protein Ro 45-2081 (lenercept): a double blind, placebo controlled dose-finding study in rheumatoid arthritisRolf Rau, Oliver Sander, Piet van Riel, et al.
RMD Open|July 3, 2021
Hydroxychloroquine in patients with inflammatory and erosive osteoarthritis of the hands: results of the OA-TREAT study-a randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trialClaudia Kedor, Jacqueline Detert, Rolf Rau, et al.
Arthritis and Rheumatism|April 16, 2002
How to report radiographic data in randomized clinical trials in rheumatoid arthritis: guidelines from a roundtable discussionDésirée van der Heijde, Lee Simon, Josef Smolen, et al.
Arthritis Research & Therapy|July 4, 2007
Expert agreement confirms that negative changes in hand and foot radiographs are a surrogate for repair in patients with rheumatoid arthritisDésirée van der Heijde, Robert Landewé, Annelies Boonen, et al.
Arthritis and Rheumatism|April 29, 2006
Association of the IL4R single-nucleotide polymorphism I50V with rapidly erosive rheumatoid arthritisIryna Prots, Alla Skapenko, Jörg Wendler, et al.
Arthritis and Rheumatism|October 29, 2005
Infections in patients with rheumatoid arthritis treated with biologic agentsJoachim Listing, Anja Strangfeld, Sonja Kary, et al.
The Journal of Rheumatology|November 5, 2002
A single dose, placebo controlled study of the fully human anti-tumor necrosis factor-alpha antibody adalimumab (D2E7) in patients with rheumatoid arthritisAlfons den Broeder, Leo van de Putte, Rolf Rau, et al.
The Journal of Rheumatology|May 8, 2003
Repair of erosions in rheumatoid arthritis does occur. Results from 2 studies by the OMERACT Subcommittee on Healing of ErosionsJohn T Sharp, Désirée Van Der Heijde, Maarten Boers, et al.
Annals of the Rheumatic Diseases|June 29, 2012
Induction therapy with adalimumab plus methotrexate for 24 weeks followed by methotrexate monotherapy up to week 48 versus methotrexate therapy alone for DMARD-naive patients with early rheumatoid arthritis: HIT HARD, an investigator-initiated studyJacqueline Detert, Hans Bastian, Joachim Listing, et al.
Annals of the Rheumatic Diseases|April 7, 2007
QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countriesTuulikki Sokka, Hannu Kautiainen, Sergio Toloza, et al.
Pageof 5